With Omicron becoming the dominant COVID-19 variant in the country, and with its reputation of being a ‘milder’ form of the disease, there is a debate raging on what treatment methodologies are appropriate. Should we adopt a conservative line or an aggressive line to treat Omicron? The responses to SARS-CoV-2 have been changing constantly, whether in the form of treatment or social restrictions.
Here we discuss the question and the challenges of responding to an evolving pandemic.
Guests: Subramanian Swaminathan , Director, Infectious Diseases and Infection Control, Gleneagles Global Hospitals, Chennai; V . Ramasubramanian , Senior Infectious Diseases Consultant, Apollo Hospitals, Chennai
Host:
Read the Parley article here .
You can now find The Hindu ’s podcasts on Spotify, Apple Podcasts and Stitcher.
Search for Parley by The Hindu . Write to us with comments and feedback at socmed4@thehindu.co.in
Published - January 27, 2022 11:32 pm IST
